Key result
Chemical modification revealed significant conformational differences in the C-terminal region of SHaPrP 27-30 compared to rSHaPrP(90-231), including loss of solvent accessibility of Y225 and Y226.
Chemical modification and mass spectrometry reveal significant conformational differences between normal and scrapie prion proteins, aiding in the structural modeling of PrPSc.
Provides structural insights into prion protein misfolding but should not yet change clinical practice;.
We used two chemical modifiers, tetranitromethane (TNM) and acetic anhydride (Ac(2)O), which specifically target accessible tyrosine and lysine residues, respectively, to modify recombinant Syrian hamster PrP(90-231) [rSHaPrP(90-231)] and SHaPrP 27-30, the proteinase K-resistant core of PrP(Sc) isolated from brain of scrapie-infected Syrian hamsters. Our aim was to find locations of conformational change. Modified proteins were subjected to in-gel proteolytic digestion with trypsin or chymotrypsin and subsequent analysis by mass spectrometry (MALDI-TOF). Several differences in chemical reactivity were observed. With TNM, the most conspicuous reactivity difference seen involves peptide E(221)-R(229) (containing Y(225) and Y(226)), which in rSHaPrP(90-231) was much more extensively modified than in SHaPrP 27-30; peptide H(111)-R(136), containing Y(128), was also more modified in rSHaPrP(90-231). Conversely, peptides Y(149)-R(151), Y(157)-R(164), and R(151)-Y(162) suffered more extensive modification in SHaPrP 27-30. Acetic anhydride modified very extensively peptide G(90)-K(106), containing K(101), K(104), K(106), and the amino terminus, in both rSHaPrP(90-231) and SHaPrP 27-30. These results suggest that (1) SHaPrP 27-30 exhibits important conformational differences in the C-terminal region with respect to rSHaPrP(90-231), resulting in the loss of solvent accessibility of Y(225) and Y(226), very solvent-exposed in the latter conformation; because other results suggest preservation of the two C-terminal helices, this might mean that these are tightly packed in SHaPrP 27-30. (2) On the other hand, tyrosines contained in the stretch spanning approximately Y(149)-R(164) are more accessible in SHaPrP 27-30, suggesting rearrangements in α-helix H1 and the short β-sheet of rSHaPrP(90-231). (3) The amino-terminal region of SHaPrP 27-30 is very accessible. These data should help in the validation and construction of structural models of PrP(Sc).
No takes yet. Share an insight, caveat, or question.
Gong et al. (2011) studied Prion disease. Chemical modification with tetranitromethane and acetic anhydride vs. Recombinant Syrian hamster PrP(90-231) was evaluated on Chemical reactivity of tyrosine and lysine residues to identify conformational changes. Chemical modification revealed significant conformational differences in the C-terminal region of SHaPrP 27-30 compared to rSHaPrP(90-231), including loss of solvent accessibility of Y225 and Y226.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: